LipoScience appoints a new Chief Medical Officer

LipoScience (LPDX +2%) appoints William Cromwell, M.D., as the company's chief medical officer.

He joins LPDX for a second time, having previously served in the same position from 1999 - 2005.

Cromwell replaces Robert M Honigberg, who announced last month that he was resigning effective September 17 for family-related reasons.

From other sites
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs